Skip to main content
. 2022 Feb 15;15:1005–1015. doi: 10.2147/JIR.S352250

Table 1.

Relationship Between NRI-HGS Score and All-Cause Mortality in Patients with Cancer Cachexia

NRI-HGS Score Model 1
HR (95% CI)
p value Adjusted Model 2
HR (95% CI)
p value Adjusted Model 3
HR (95% CI)
p value
Training cohort
Normal Ref Ref Ref
Mild 1.652 (1.334–2.046) <0.001 1.4 (1.126–1.742) 0.003 1.324 (1.059–1.656) 0.014
Moderate 2.746 (2.23–3.381) <0.001 2.455 (1.957–3.08) <0.001 2.176 (1.718–2.756) <0.001
Severe 4.426 (3.481–5.628) <0.001 3.374 (2.546–4.473) <0.001 2.745 (2.023–3.725) <0.001
Validation cohort
Normal Ref Ref Ref
Mild 2.397 (1.648–3.486) <0.001 2.018 (1.379–2.954) <0.001 1.826 (1.233–2.705) 0.003
Moderate 3.378 (2.318–4.921) <0.001 2.831 (1.897–4.225) <0.001 2.298 (1.500–3.52) <0.001
Severe 6.064 (4.008–9.173) <0.001 4.199 (2.632–6.698) <0.001 2.855 (1.684–4.84) <0.001

Notes: Model 1: No adjusted. Model 2: Adjusted for age, BMI, TNM stage, surgery, radiotherapy, chemotherapy, hypertension, diabetes, smoke, alcohol, family history, weight loss. Model 3: Adjusted for age, BMI, TNM stage, surgery, radiotherapy, chemotherapy, hypertension, diabetes, smoke, alcohol, family history, weight loss, WBC, neutrophil, lymphocyte, platelet, RBC, hemoglobin.